

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.74689194 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.70832408 |
| 3 | synaptic vesicle maturation (GO:0016188) | 5.53954841 |
| 4 | glutamate secretion (GO:0014047) | 5.50311410 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.48306601 |
| 6 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.22054979 |
| 7 | vocalization behavior (GO:0071625) | 5.20095944 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.01538360 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.00422216 |
| 10 | locomotory exploration behavior (GO:0035641) | 4.95358804 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.92942569 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.66484972 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 4.63330757 |
| 14 | protein localization to synapse (GO:0035418) | 4.60159359 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.58427019 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.53302431 |
| 17 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.45943554 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.45372950 |
| 19 | exploration behavior (GO:0035640) | 4.10768534 |
| 20 | neuronal action potential propagation (GO:0019227) | 4.04630158 |
| 21 | proline transport (GO:0015824) | 4.02661484 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 3.98799528 |
| 23 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.91319594 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 3.90047963 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 3.89421984 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 3.81280855 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.80876226 |
| 28 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.80408946 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 3.77749542 |
| 30 | positive regulation of synapse maturation (GO:0090129) | 3.74632447 |
| 31 | activation of protein kinase A activity (GO:0034199) | 3.70320666 |
| 32 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.64647937 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63162107 |
| 34 | neurotransmitter transport (GO:0006836) | 3.60538681 |
| 35 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.57436160 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 3.57007729 |
| 37 | piRNA metabolic process (GO:0034587) | 3.51628652 |
| 38 | postsynaptic membrane organization (GO:0001941) | 3.48196287 |
| 39 | cullin deneddylation (GO:0010388) | 3.46851745 |
| 40 | positive regulation of membrane potential (GO:0045838) | 3.46113007 |
| 41 | long-term synaptic potentiation (GO:0060291) | 3.40303124 |
| 42 | synaptic vesicle endocytosis (GO:0048488) | 3.39605221 |
| 43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.39074888 |
| 44 | regulation of neurotransmitter secretion (GO:0046928) | 3.36508575 |
| 45 | regulation of neurotransmitter levels (GO:0001505) | 3.34899762 |
| 46 | regulation of protein glycosylation (GO:0060049) | 3.34569548 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.32929859 |
| 48 | long-term memory (GO:0007616) | 3.29966089 |
| 49 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.28099419 |
| 50 | regulation of cofactor metabolic process (GO:0051193) | 3.26849684 |
| 51 | regulation of coenzyme metabolic process (GO:0051196) | 3.26849684 |
| 52 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.26695536 |
| 53 | regulation of synaptic plasticity (GO:0048167) | 3.26493259 |
| 54 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26304652 |
| 55 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.25767611 |
| 56 | neuron recognition (GO:0008038) | 3.25424584 |
| 57 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.25134156 |
| 58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24246143 |
| 59 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.23939116 |
| 60 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.21251106 |
| 61 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.19493207 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.18836522 |
| 63 | proteasome assembly (GO:0043248) | 3.16466401 |
| 64 | inositol phosphate catabolic process (GO:0071545) | 3.16436668 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.14479950 |
| 66 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.13870551 |
| 67 | inositol phosphate dephosphorylation (GO:0046855) | 3.13870551 |
| 68 | protein deneddylation (GO:0000338) | 3.13666214 |
| 69 | cerebellar granule cell differentiation (GO:0021707) | 3.12612322 |
| 70 | regulation of neurotransmitter transport (GO:0051588) | 3.12366462 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 3.10955208 |
| 72 | presynaptic membrane organization (GO:0097090) | 3.08848942 |
| 73 | vesicle transport along microtubule (GO:0047496) | 3.07945202 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07549256 |
| 75 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.06288824 |
| 76 | amino acid salvage (GO:0043102) | 3.06227050 |
| 77 | L-methionine salvage (GO:0071267) | 3.06227050 |
| 78 | L-methionine biosynthetic process (GO:0071265) | 3.06227050 |
| 79 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.04240710 |
| 80 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.03522205 |
| 81 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.02840373 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.01811352 |
| 83 | dendritic spine morphogenesis (GO:0060997) | 3.01596187 |
| 84 | response to histamine (GO:0034776) | 3.01231350 |
| 85 | positive regulation of mitochondrial fission (GO:0090141) | 3.01217408 |
| 86 | regulation of meiosis I (GO:0060631) | 2.99837632 |
| 87 | regulation of vesicle fusion (GO:0031338) | 2.99264976 |
| 88 | auditory behavior (GO:0031223) | 2.98581337 |
| 89 | regulation of sulfur metabolic process (GO:0042762) | 2.98457446 |
| 90 | ketone body metabolic process (GO:1902224) | 2.98135597 |
| 91 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.97686805 |
| 92 | cell migration in hindbrain (GO:0021535) | 2.97016120 |
| 93 | positive regulation of synaptic transmission (GO:0050806) | 2.96812697 |
| 94 | retinal cone cell development (GO:0046549) | 2.95638628 |
| 95 | behavioral response to cocaine (GO:0048148) | 2.94219736 |
| 96 | neuromuscular process controlling balance (GO:0050885) | 2.92637283 |
| 97 | axonal fasciculation (GO:0007413) | 2.92279860 |
| 98 | magnesium ion transport (GO:0015693) | 2.92083040 |
| 99 | membrane depolarization during action potential (GO:0086010) | 2.91701511 |
| 100 | innervation (GO:0060384) | 2.91033510 |
| 101 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.90931781 |
| 102 | synaptic transmission (GO:0007268) | 2.90848475 |
| 103 | response to auditory stimulus (GO:0010996) | 2.90744088 |
| 104 | establishment of synaptic vesicle localization (GO:0097480) | 2.90603890 |
| 105 | synaptic vesicle transport (GO:0048489) | 2.90603890 |
| 106 | dendrite morphogenesis (GO:0048813) | 2.90378335 |
| 107 | synapse assembly (GO:0007416) | 2.87192235 |
| 108 | macroautophagy (GO:0016236) | 2.86522621 |
| 109 | organelle transport along microtubule (GO:0072384) | 2.86213426 |
| 110 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.84644852 |
| 111 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.84644852 |
| 112 | regulation of synaptic transmission (GO:0050804) | 2.84466583 |
| 113 | cell communication by electrical coupling (GO:0010644) | 2.84269510 |
| 114 | negative regulation of dendrite development (GO:2000171) | 2.83767723 |
| 115 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.83556182 |
| 116 | transferrin transport (GO:0033572) | 2.83366981 |
| 117 | membrane depolarization (GO:0051899) | 2.83165163 |
| 118 | regulation of synapse maturation (GO:0090128) | 2.83161377 |
| 119 | nucleotide transmembrane transport (GO:1901679) | 2.81934559 |
| 120 | establishment of vesicle localization (GO:0051650) | 2.81231115 |
| 121 | learning (GO:0007612) | 2.81199332 |
| 122 | sodium ion export (GO:0071436) | 2.80572925 |
| 123 | detection of calcium ion (GO:0005513) | 2.80211026 |
| 124 | acrosome assembly (GO:0001675) | 2.80165176 |
| 125 | cellular ketone body metabolic process (GO:0046950) | 2.79013968 |
| 126 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.77941552 |
| 127 | COPII vesicle coating (GO:0048208) | 2.74324413 |
| 128 | signal peptide processing (GO:0006465) | 2.71097891 |
| 129 | lipid particle organization (GO:0034389) | 2.65962833 |
| 130 | dopamine transport (GO:0015872) | 2.64583382 |
| 131 | acrosome reaction (GO:0007340) | 2.64165263 |
| 132 | peroxisome fission (GO:0016559) | 2.62750675 |
| 133 | DNA methylation involved in gamete generation (GO:0043046) | 2.62201574 |
| 134 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.60517522 |
| 135 | positive regulation of glycolytic process (GO:0045821) | 2.59281580 |
| 136 | peptidyl-cysteine modification (GO:0018198) | 2.59035646 |
| 137 | isoprenoid biosynthetic process (GO:0008299) | 2.56874390 |
| 138 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.56822871 |
| 139 | ribonucleoprotein complex disassembly (GO:0032988) | 2.56720069 |
| 140 | melanin biosynthetic process (GO:0042438) | 2.55550067 |
| 141 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.53776509 |
| 142 | protein localization to cilium (GO:0061512) | 2.50344149 |
| 143 | polyol catabolic process (GO:0046174) | 2.48983459 |
| 144 | vascular smooth muscle contraction (GO:0014829) | 2.48409465 |
| 145 | sterol biosynthetic process (GO:0016126) | 2.46390173 |
| 146 | secondary metabolite biosynthetic process (GO:0044550) | 2.46311100 |
| 147 | membrane budding (GO:0006900) | 2.45662783 |
| 148 | branched-chain amino acid catabolic process (GO:0009083) | 2.44240552 |
| 149 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.42609687 |
| 150 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.40815682 |
| 151 | calcium ion-dependent exocytosis (GO:0017156) | 2.39099371 |
| 152 | cholesterol biosynthetic process (GO:0006695) | 2.37563244 |
| 153 | protein localization to Golgi apparatus (GO:0034067) | 2.37328794 |
| 154 | response to redox state (GO:0051775) | 2.37283801 |
| 155 | tricarboxylic acid cycle (GO:0006099) | 2.36483760 |
| 156 | positive regulation of protein autophosphorylation (GO:0031954) | 2.35324572 |
| 157 | regulation of acrosome reaction (GO:0060046) | 2.34324937 |
| 158 | regulation of oxidative phosphorylation (GO:0002082) | 2.33666750 |
| 159 | righting reflex (GO:0060013) | 2.32356410 |
| 160 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.30910478 |
| 161 | positive regulation of actin filament depolymerization (GO:0030836) | 2.30822585 |
| 162 | xenobiotic catabolic process (GO:0042178) | 2.29575335 |
| 163 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.29261255 |
| 164 | platelet dense granule organization (GO:0060155) | 2.28453392 |
| 165 | dopamine biosynthetic process (GO:0042416) | 2.26467445 |
| 166 | protein targeting to Golgi (GO:0000042) | 2.24428005 |
| 167 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.23659727 |
| 168 | Golgi to endosome transport (GO:0006895) | 2.22586519 |
| 169 | methionine metabolic process (GO:0006555) | 2.22452045 |
| 170 | establishment of melanosome localization (GO:0032401) | 2.22314286 |
| 171 | melanosome transport (GO:0032402) | 2.22128616 |
| 172 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.22110718 |
| 173 | methionine biosynthetic process (GO:0009086) | 2.21730023 |
| 174 | relaxation of smooth muscle (GO:0044557) | 2.21281657 |
| 175 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.20849248 |
| 176 | multicellular organism reproduction (GO:0032504) | 2.19846404 |
| 177 | protein neddylation (GO:0045116) | 2.19416732 |
| 178 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.18929302 |
| 179 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.18929302 |
| 180 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.18929302 |
| 181 | anterograde synaptic vesicle transport (GO:0048490) | 2.18244904 |
| 182 | establishment of pigment granule localization (GO:0051905) | 2.18082108 |
| 183 | pigment granule transport (GO:0051904) | 2.17712506 |
| 184 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.16570344 |
| 185 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.15562373 |
| 186 | anterograde axon cargo transport (GO:0008089) | 2.15003758 |
| 187 | respiratory chain complex IV assembly (GO:0008535) | 2.14353539 |
| 188 | cellular response to leptin stimulus (GO:0044320) | 2.13518316 |
| 189 | fatty acid elongation (GO:0030497) | 2.13426997 |
| 190 | myelin assembly (GO:0032288) | 2.12811466 |
| 191 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.12369246 |
| 192 | establishment of protein localization to Golgi (GO:0072600) | 2.11210378 |
| 193 | muscle cell cellular homeostasis (GO:0046716) | 2.11010562 |
| 194 | succinate metabolic process (GO:0006105) | 2.10766035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28494204 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80560877 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03488265 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.99220354 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89848161 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.78453309 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71873088 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.71322719 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46312570 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46312570 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44106975 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.44103529 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.43493604 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.42371454 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37851436 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.37750975 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36892644 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.34944382 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.32028645 |
| 20 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25705661 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.22627659 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.14517176 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.12847435 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.02544224 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02258516 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.02242077 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01085815 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00098683 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.99839558 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.99104682 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97318382 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.96553942 |
| 33 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.94570547 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90160866 |
| 35 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.90022121 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84823492 |
| 37 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80974990 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.78548059 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76080238 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.74295409 |
| 41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.71512948 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.70581069 |
| 43 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.69145144 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.66596982 |
| 45 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.64900829 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63500974 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.60497485 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.59803242 |
| 49 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.55336243 |
| 50 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.54156484 |
| 51 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.54114992 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.53328726 |
| 53 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.52983023 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51768009 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.51421043 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50131435 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.49184939 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49122575 |
| 59 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46222092 |
| 60 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.45851574 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45213134 |
| 62 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42239842 |
| 63 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.39058750 |
| 64 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.39022494 |
| 65 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38514920 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.37085233 |
| 67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.36757901 |
| 68 | AR_25329375_ChIP-Seq_VCAP_Human | 1.34949106 |
| 69 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.34557224 |
| 70 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34456665 |
| 71 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34012024 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33748231 |
| 73 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.32746335 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32727993 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31644604 |
| 76 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.30793508 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.30793508 |
| 78 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.30235467 |
| 79 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29646503 |
| 80 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.28648747 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.28188239 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28183186 |
| 83 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28030443 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27318450 |
| 85 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27318450 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26103083 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.26080073 |
| 88 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.24450185 |
| 89 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.24358361 |
| 90 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.24314283 |
| 91 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.24304038 |
| 92 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.24011594 |
| 93 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23727977 |
| 94 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22078149 |
| 95 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22032252 |
| 96 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22023606 |
| 97 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.20527727 |
| 98 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19560737 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18765258 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.18066537 |
| 101 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.15922840 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.15756021 |
| 103 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.14931896 |
| 104 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.14054187 |
| 105 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13895170 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13684758 |
| 107 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.13653016 |
| 108 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.13330358 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.13321326 |
| 110 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12879709 |
| 111 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12140643 |
| 112 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11241876 |
| 113 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11038827 |
| 114 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10614411 |
| 115 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.10534850 |
| 116 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.10345071 |
| 117 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.09569633 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09381586 |
| 119 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09246209 |
| 120 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09050484 |
| 121 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08878288 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08505595 |
| 123 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08336193 |
| 124 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.07778934 |
| 125 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07583667 |
| 126 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07417887 |
| 127 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.07329964 |
| 128 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06574081 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05751759 |
| 130 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03752990 |
| 131 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03503496 |
| 132 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.03251552 |
| 133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03197948 |
| 134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02500662 |
| 135 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02440128 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99926291 |
| 137 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98569964 |
| 138 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97692475 |
| 139 | JUN_21703547_ChIP-Seq_K562_Human | 0.96667445 |
| 140 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96646946 |
| 141 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95535318 |
| 142 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95351219 |
| 143 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94805580 |
| 144 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93058660 |
| 145 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92449094 |
| 146 | VDR_22108803_ChIP-Seq_LS180_Human | 0.92386682 |
| 147 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.91566915 |
| 148 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89636617 |
| 149 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88805917 |
| 150 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.87358681 |
| 151 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87273109 |
| 152 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87273109 |
| 153 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86945546 |
| 154 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86554116 |
| 155 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86485613 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86119373 |
| 157 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85595494 |
| 158 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84482237 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.03310369 |
| 2 | MP0003880_abnormal_central_pattern | 4.54291114 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.02993666 |
| 4 | MP0004270_analgesia | 3.76325639 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.28999752 |
| 6 | MP0009745_abnormal_behavioral_response | 3.27697222 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.11020543 |
| 8 | MP0009046_muscle_twitch | 3.10998422 |
| 9 | MP0002064_seizures | 3.09463534 |
| 10 | MP0000372_irregular_coat_pigmentation | 3.06556517 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.85024882 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.76093168 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.73359435 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.70147728 |
| 15 | MP0002102_abnormal_ear_morphology | 2.68954928 |
| 16 | MP0005171_absent_coat_pigmentation | 2.66110190 |
| 17 | MP0000015_abnormal_ear_pigmentation | 2.64410951 |
| 18 | MP0002736_abnormal_nociception_after | 2.51581316 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.50146952 |
| 20 | MP0002822_catalepsy | 2.48386879 |
| 21 | MP0002272_abnormal_nervous_system | 2.47759042 |
| 22 | MP0004147_increased_porphyrin_level | 2.38181111 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.31230124 |
| 24 | MP0001486_abnormal_startle_reflex | 2.27308048 |
| 25 | MP0005408_hypopigmentation | 2.19466984 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.12956896 |
| 27 | MP0002909_abnormal_adrenal_gland | 2.07344070 |
| 28 | MP0001501_abnormal_sleep_pattern | 2.05628063 |
| 29 | MP0001970_abnormal_pain_threshold | 2.02955076 |
| 30 | MP0004084_abnormal_cardiac_muscle | 2.00835354 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.99216732 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.98556935 |
| 33 | MP0006054_spinal_hemorrhage | 1.92743255 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.91656292 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.90534392 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.88045281 |
| 37 | MP0003195_calcinosis | 1.87877804 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.84244673 |
| 39 | MP0003329_amyloid_beta_deposits | 1.83988300 |
| 40 | MP0003879_abnormal_hair_cell | 1.77782139 |
| 41 | MP0003950_abnormal_plasma_membrane | 1.77684705 |
| 42 | MP0004924_abnormal_behavior | 1.77572733 |
| 43 | MP0005386_behavior/neurological_phenoty | 1.77572733 |
| 44 | MP0002184_abnormal_innervation | 1.76903274 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.76757266 |
| 46 | MP0004858_abnormal_nervous_system | 1.76623670 |
| 47 | MP0008569_lethality_at_weaning | 1.72213336 |
| 48 | MP0003787_abnormal_imprinting | 1.70898891 |
| 49 | MP0001984_abnormal_olfaction | 1.70780878 |
| 50 | MP0003718_maternal_effect | 1.68876756 |
| 51 | MP0003186_abnormal_redox_activity | 1.67345026 |
| 52 | MP0002557_abnormal_social/conspecific_i | 1.66635134 |
| 53 | MP0000778_abnormal_nervous_system | 1.66399278 |
| 54 | MP0005174_abnormal_tail_pigmentation | 1.60133043 |
| 55 | MP0003122_maternal_imprinting | 1.54269117 |
| 56 | MP0003868_abnormal_feces_composition | 1.52939150 |
| 57 | MP0000955_abnormal_spinal_cord | 1.50634795 |
| 58 | MP0006036_abnormal_mitochondrial_physio | 1.50587469 |
| 59 | MP0000427_abnormal_hair_cycle | 1.50136540 |
| 60 | MP0008775_abnormal_heart_ventricle | 1.49840110 |
| 61 | MP0000749_muscle_degeneration | 1.44855724 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.44727219 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.44019889 |
| 64 | MP0000013_abnormal_adipose_tissue | 1.41654315 |
| 65 | MP0002066_abnormal_motor_capabilities/c | 1.40146986 |
| 66 | MP0005253_abnormal_eye_physiology | 1.39666069 |
| 67 | MP0002882_abnormal_neuron_morphology | 1.36338783 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.30465025 |
| 69 | MP0001529_abnormal_vocalization | 1.29082994 |
| 70 | MP0003633_abnormal_nervous_system | 1.28652173 |
| 71 | MP0002095_abnormal_skin_pigmentation | 1.27587792 |
| 72 | MP0000751_myopathy | 1.26001605 |
| 73 | MP0005645_abnormal_hypothalamus_physiol | 1.25480934 |
| 74 | MP0001905_abnormal_dopamine_level | 1.24853633 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.23859264 |
| 76 | MP0001502_abnormal_circadian_rhythm | 1.23803830 |
| 77 | MP0006072_abnormal_retinal_apoptosis | 1.20279000 |
| 78 | MP0000647_abnormal_sebaceous_gland | 1.16820270 |
| 79 | MP0008875_abnormal_xenobiotic_pharmacok | 1.16069336 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 1.15499005 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.14477712 |
| 82 | MP0005332_abnormal_amino_acid | 1.12215974 |
| 83 | MP0002876_abnormal_thyroid_physiology | 1.12162549 |
| 84 | MP0005410_abnormal_fertilization | 1.11599800 |
| 85 | MP0004885_abnormal_endolymph | 1.10992025 |
| 86 | MP0004142_abnormal_muscle_tone | 1.10785118 |
| 87 | MP0002972_abnormal_cardiac_muscle | 1.08421911 |
| 88 | MP0002269_muscular_atrophy | 1.07858063 |
| 89 | MP0004233_abnormal_muscle_weight | 1.07420292 |
| 90 | MP0003631_nervous_system_phenotype | 1.07108423 |
| 91 | MP0001188_hyperpigmentation | 1.05697234 |
| 92 | MP0005248_abnormal_Harderian_gland | 1.05247756 |
| 93 | MP0000371_diluted_coat_color | 1.02469171 |
| 94 | MP0002229_neurodegeneration | 1.01414663 |
| 95 | MP0002332_abnormal_exercise_endurance | 1.01081071 |
| 96 | MP0002152_abnormal_brain_morphology | 1.00422792 |
| 97 | MP0000639_abnormal_adrenal_gland | 0.97683920 |
| 98 | MP0005535_abnormal_body_temperature | 0.96791325 |
| 99 | MP0002069_abnormal_eating/drinking_beha | 0.96624971 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.96591884 |
| 101 | MP0002877_abnormal_melanocyte_morpholog | 0.96348930 |
| 102 | MP0003646_muscle_fatigue | 0.95611771 |
| 103 | MP0005551_abnormal_eye_electrophysiolog | 0.94055048 |
| 104 | MP0004085_abnormal_heartbeat | 0.93966714 |
| 105 | MP0004215_abnormal_myocardial_fiber | 0.93126430 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.93015220 |
| 107 | MP0008872_abnormal_physiological_respon | 0.89810768 |
| 108 | MP0001661_extended_life_span | 0.88837627 |
| 109 | MP0004130_abnormal_muscle_cell | 0.88068497 |
| 110 | MP0000604_amyloidosis | 0.87034843 |
| 111 | MP0003183_abnormal_peptide_metabolism | 0.86940792 |
| 112 | MP0010329_abnormal_lipoprotein_level | 0.85408317 |
| 113 | MP0008874_decreased_physiological_sensi | 0.83747318 |
| 114 | MP0001756_abnormal_urination | 0.82740249 |
| 115 | MP0004484_altered_response_of | 0.79660051 |
| 116 | MP0000003_abnormal_adipose_tissue | 0.79130726 |
| 117 | MP0004043_abnormal_pH_regulation | 0.79039250 |
| 118 | MP0005083_abnormal_biliary_tract | 0.78674203 |
| 119 | MP0003634_abnormal_glial_cell | 0.78155659 |
| 120 | MP0001324_abnormal_eye_pigmentation | 0.77032449 |
| 121 | MP0004272_abnormal_basement_membrane | 0.75982120 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.75810768 |
| 123 | MP0005365_abnormal_bile_salt | 0.73339094 |
| 124 | MP0001963_abnormal_hearing_physiology | 0.73318467 |
| 125 | MP0004134_abnormal_chest_morphology | 0.73082361 |
| 126 | MP0001177_atelectasis | 0.72738241 |
| 127 | MP0005395_other_phenotype | 0.72282059 |
| 128 | MP0003890_abnormal_embryonic-extraembry | 0.71988543 |
| 129 | MP0002751_abnormal_autonomic_nervous | 0.71839427 |
| 130 | MP0002177_abnormal_outer_ear | 0.71509159 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.71453614 |
| 132 | MP0009840_abnormal_foam_cell | 0.71312729 |
| 133 | MP0002090_abnormal_vision | 0.70911026 |
| 134 | MP0003252_abnormal_bile_duct | 0.70327435 |
| 135 | MP0002160_abnormal_reproductive_system | 0.70052636 |
| 136 | MP0003632_abnormal_nervous_system | 0.68949431 |
| 137 | MP0002752_abnormal_somatic_nervous | 0.68070972 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.67370239 |
| 139 | MP0001664_abnormal_digestion | 0.66644590 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.65882357 |
| 141 | MP0002638_abnormal_pupillary_reflex | 0.60856511 |
| 142 | MP0005394_taste/olfaction_phenotype | 0.59329905 |
| 143 | MP0005499_abnormal_olfactory_system | 0.59329905 |
| 144 | MP0003137_abnormal_impulse_conducting | 0.58935603 |
| 145 | MP0003690_abnormal_glial_cell | 0.57786989 |
| 146 | MP0004036_abnormal_muscle_relaxation | 0.57567284 |
| 147 | MP0005187_abnormal_penis_morphology | 0.56689389 |
| 148 | MP0005620_abnormal_muscle_contractility | 0.55605720 |
| 149 | MP0004742_abnormal_vestibular_system | 0.54755052 |
| 150 | MP0003283_abnormal_digestive_organ | 0.54024535 |
| 151 | MP0003075_altered_response_to | 0.52523742 |
| 152 | MP0003956_abnormal_body_size | 0.51665062 |
| 153 | MP0003172_abnormal_lysosome_physiology | 0.51264442 |
| 154 | MP0002653_abnormal_ependyma_morphology | 0.50881386 |
| 155 | MP0005448_abnormal_energy_balance | 0.50615065 |
| 156 | MP0001943_abnormal_respiration | 0.50597913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.95425852 |
| 2 | Myokymia (HP:0002411) | 5.87226138 |
| 3 | Focal seizures (HP:0007359) | 5.14865054 |
| 4 | Visual hallucinations (HP:0002367) | 4.99802550 |
| 5 | Atonic seizures (HP:0010819) | 4.97229074 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.95026025 |
| 7 | Febrile seizures (HP:0002373) | 4.45524730 |
| 8 | Absence seizures (HP:0002121) | 4.09566416 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.04333098 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 3.73782067 |
| 11 | Hyperventilation (HP:0002883) | 3.71749370 |
| 12 | Dialeptic seizures (HP:0011146) | 3.67175566 |
| 13 | Papillary thyroid carcinoma (HP:0002895) | 3.60643011 |
| 14 | Pheochromocytoma (HP:0002666) | 3.54073511 |
| 15 | Action tremor (HP:0002345) | 3.48064524 |
| 16 | Tongue fasciculations (HP:0001308) | 3.39771533 |
| 17 | Ankle clonus (HP:0011448) | 3.27339562 |
| 18 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.24112327 |
| 19 | Neuroendocrine neoplasm (HP:0100634) | 3.16658890 |
| 20 | Depression (HP:0000716) | 3.15487780 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.14618843 |
| 22 | Metaphyseal dysplasia (HP:0100255) | 3.14335336 |
| 23 | Mutism (HP:0002300) | 3.10004614 |
| 24 | Broad-based gait (HP:0002136) | 3.07582793 |
| 25 | Progressive inability to walk (HP:0002505) | 3.07111066 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.06305617 |
| 27 | Poor eye contact (HP:0000817) | 3.05630569 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.04245087 |
| 29 | Truncal ataxia (HP:0002078) | 3.03676644 |
| 30 | Gaze-evoked nystagmus (HP:0000640) | 2.97272791 |
| 31 | Abnormality of the fovea (HP:0000493) | 2.97179189 |
| 32 | Medial flaring of the eyebrow (HP:0010747) | 2.97026664 |
| 33 | Dysdiadochokinesis (HP:0002075) | 2.95949227 |
| 34 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.94794264 |
| 35 | Hypoplasia of the fovea (HP:0007750) | 2.94794264 |
| 36 | Renal cortical cysts (HP:0000803) | 2.90879213 |
| 37 | Limb dystonia (HP:0002451) | 2.89733069 |
| 38 | Cutaneous melanoma (HP:0012056) | 2.89154148 |
| 39 | Impaired social interactions (HP:0000735) | 2.87305897 |
| 40 | Abnormal social behavior (HP:0012433) | 2.87305897 |
| 41 | Methylmalonic acidemia (HP:0002912) | 2.85847926 |
| 42 | Muscle fibrillation (HP:0010546) | 2.85765305 |
| 43 | Termporal pattern (HP:0011008) | 2.84316165 |
| 44 | Insidious onset (HP:0003587) | 2.84316165 |
| 45 | Polyphagia (HP:0002591) | 2.79521049 |
| 46 | Abnormality of the lower motor neuron (HP:0002366) | 2.79311203 |
| 47 | Urinary urgency (HP:0000012) | 2.76448637 |
| 48 | Anxiety (HP:0000739) | 2.76384930 |
| 49 | Genetic anticipation (HP:0003743) | 2.76308043 |
| 50 | Torticollis (HP:0000473) | 2.75738222 |
| 51 | Hypoglycemic coma (HP:0001325) | 2.75723764 |
| 52 | Drooling (HP:0002307) | 2.71768396 |
| 53 | Excessive salivation (HP:0003781) | 2.71768396 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.71176232 |
| 55 | Papilledema (HP:0001085) | 2.69317787 |
| 56 | Ketoacidosis (HP:0001993) | 2.67190130 |
| 57 | Postural instability (HP:0002172) | 2.65759288 |
| 58 | Thyroid carcinoma (HP:0002890) | 2.63995888 |
| 59 | Dysmetric saccades (HP:0000641) | 2.61150468 |
| 60 | Amblyopia (HP:0000646) | 2.60531189 |
| 61 | EEG with generalized epileptiform discharges (HP:0011198) | 2.57084875 |
| 62 | Focal dystonia (HP:0004373) | 2.55931600 |
| 63 | Progressive macrocephaly (HP:0004481) | 2.54074590 |
| 64 | Dysmetria (HP:0001310) | 2.53707353 |
| 65 | Type II lissencephaly (HP:0007260) | 2.51934289 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.47592602 |
| 67 | Inability to walk (HP:0002540) | 2.46728018 |
| 68 | Hypothermia (HP:0002045) | 2.46131369 |
| 69 | Failure to thrive in infancy (HP:0001531) | 2.45879247 |
| 70 | Scanning speech (HP:0002168) | 2.45204011 |
| 71 | Acute necrotizing encephalopathy (HP:0006965) | 2.44773987 |
| 72 | Gait imbalance (HP:0002141) | 2.43182063 |
| 73 | Agitation (HP:0000713) | 2.40704911 |
| 74 | Abnormality of the corticospinal tract (HP:0002492) | 2.40642874 |
| 75 | Bradykinesia (HP:0002067) | 2.39953468 |
| 76 | Craniofacial dystonia (HP:0012179) | 2.39239493 |
| 77 | Spastic gait (HP:0002064) | 2.37757681 |
| 78 | Hypokinesia (HP:0002375) | 2.31339488 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.30084410 |
| 80 | Diplopia (HP:0000651) | 2.30084410 |
| 81 | Proximal tubulopathy (HP:0000114) | 2.29104132 |
| 82 | Short tibia (HP:0005736) | 2.28736010 |
| 83 | Resting tremor (HP:0002322) | 2.28070962 |
| 84 | Fetal akinesia sequence (HP:0001989) | 2.27344715 |
| 85 | Hepatic necrosis (HP:0002605) | 2.26304017 |
| 86 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.25500949 |
| 87 | Impaired vibratory sensation (HP:0002495) | 2.25410662 |
| 88 | Increased CSF lactate (HP:0002490) | 2.25368296 |
| 89 | Calf muscle hypertrophy (HP:0008981) | 2.23511211 |
| 90 | Acute encephalopathy (HP:0006846) | 2.23278935 |
| 91 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.23217688 |
| 92 | Impaired smooth pursuit (HP:0007772) | 2.22579322 |
| 93 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.22569373 |
| 94 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.20682697 |
| 95 | Status epilepticus (HP:0002133) | 2.19592819 |
| 96 | Lower limb muscle weakness (HP:0007340) | 2.17960258 |
| 97 | Nephrogenic diabetes insipidus (HP:0009806) | 2.17356557 |
| 98 | Pancreatic cysts (HP:0001737) | 2.16467955 |
| 99 | Amyotrophic lateral sclerosis (HP:0007354) | 2.14889957 |
| 100 | Delayed gross motor development (HP:0002194) | 2.14362444 |
| 101 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.12852161 |
| 102 | Albinism (HP:0001022) | 2.12468351 |
| 103 | Oligomenorrhea (HP:0000876) | 2.12443558 |
| 104 | 3-Methylglutaconic aciduria (HP:0003535) | 2.11982955 |
| 105 | Bundle branch block (HP:0011710) | 2.10992872 |
| 106 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.09412246 |
| 107 | Degeneration of anterior horn cells (HP:0002398) | 2.08444336 |
| 108 | Abnormality of the anterior horn cell (HP:0006802) | 2.08444336 |
| 109 | Akinesia (HP:0002304) | 2.08259764 |
| 110 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.07539090 |
| 111 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.07539090 |
| 112 | Palpitations (HP:0001962) | 2.07425437 |
| 113 | Generalized aminoaciduria (HP:0002909) | 2.07054324 |
| 114 | Congenital sensorineural hearing impairment (HP:0008527) | 2.07042038 |
| 115 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.06702561 |
| 116 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.06702561 |
| 117 | Patchy hypopigmentation of hair (HP:0011365) | 2.06329798 |
| 118 | Abnormality of vitamin B metabolism (HP:0004340) | 2.05747672 |
| 119 | Generalized hypopigmentation (HP:0007513) | 2.04639017 |
| 120 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.03860482 |
| 121 | Epidermoid cyst (HP:0200040) | 2.03707449 |
| 122 | Methylmalonic aciduria (HP:0012120) | 2.03520701 |
| 123 | Cerebral inclusion bodies (HP:0100314) | 2.02597777 |
| 124 | Poor suck (HP:0002033) | 2.02375239 |
| 125 | Stereotypic behavior (HP:0000733) | 2.01663367 |
| 126 | Abnormality of the renal cortex (HP:0011035) | 2.01603237 |
| 127 | Generalized myoclonic seizures (HP:0002123) | 2.00909768 |
| 128 | Specific learning disability (HP:0001328) | 1.99958766 |
| 129 | Blue irides (HP:0000635) | 1.99423424 |
| 130 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.99273014 |
| 131 | Impaired pain sensation (HP:0007328) | 1.99270080 |
| 132 | Abnormality of pain sensation (HP:0010832) | 1.99270080 |
| 133 | Large for gestational age (HP:0001520) | 1.98274420 |
| 134 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.98207338 |
| 135 | Abnormality of alanine metabolism (HP:0010916) | 1.98207338 |
| 136 | Hyperalaninemia (HP:0003348) | 1.98207338 |
| 137 | Syncope (HP:0001279) | 1.97655865 |
| 138 | Abnormality of methionine metabolism (HP:0010901) | 1.96463687 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.96140929 |
| 140 | Abnormal hair whorl (HP:0010721) | 1.96088621 |
| 141 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.95709368 |
| 142 | Ventricular fibrillation (HP:0001663) | 1.94044236 |
| 143 | Intention tremor (HP:0002080) | 1.92963672 |
| 144 | Hemiparesis (HP:0001269) | 1.92795224 |
| 145 | Abnormality of the calf musculature (HP:0001430) | 1.92773677 |
| 146 | Congenital primary aphakia (HP:0007707) | 1.92569376 |
| 147 | Gait ataxia (HP:0002066) | 1.92426248 |
| 148 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.90098145 |
| 149 | Absent speech (HP:0001344) | 1.89362240 |
| 150 | Upper limb muscle weakness (HP:0003484) | 1.88878342 |
| 151 | Mitochondrial inheritance (HP:0001427) | 1.88290512 |
| 152 | Hypoventilation (HP:0002791) | 1.88208651 |
| 153 | Hemiplegia (HP:0002301) | 1.88065781 |
| 154 | Abnormality of macular pigmentation (HP:0008002) | 1.86460174 |
| 155 | Megalencephaly (HP:0001355) | 1.86329216 |
| 156 | Neuronal loss in central nervous system (HP:0002529) | 1.86115794 |
| 157 | Fair hair (HP:0002286) | 1.85499640 |
| 158 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.84310779 |
| 159 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.84251661 |
| 160 | Genital tract atresia (HP:0001827) | 1.83676729 |
| 161 | Cholecystitis (HP:0001082) | 1.83029616 |
| 162 | Abnormal gallbladder physiology (HP:0012438) | 1.83029616 |
| 163 | Neurofibrillary tangles (HP:0002185) | 1.82917702 |
| 164 | Renal Fanconi syndrome (HP:0001994) | 1.82877076 |
| 165 | Clonus (HP:0002169) | 1.82693197 |
| 166 | Menstrual irregularities (HP:0000858) | 1.80897096 |
| 167 | Rigidity (HP:0002063) | 1.79694646 |
| 168 | Delusions (HP:0000746) | 1.79093208 |
| 169 | Diminished movement (HP:0002374) | 1.79056133 |
| 170 | Postural tremor (HP:0002174) | 1.78847500 |
| 171 | Hypoplasia of the uterus (HP:0000013) | 1.78810732 |
| 172 | Incomplete penetrance (HP:0003829) | 1.78686789 |
| 173 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.77029025 |
| 174 | Abnormal gallbladder morphology (HP:0012437) | 1.75550028 |
| 175 | Pachygyria (HP:0001302) | 1.74674016 |
| 176 | Retinal dysplasia (HP:0007973) | 1.72485073 |
| 177 | Glycosuria (HP:0003076) | 1.72069181 |
| 178 | Abnormality of urine glucose concentration (HP:0011016) | 1.72069181 |
| 179 | Abnormality of vitamin metabolism (HP:0100508) | 1.67340892 |
| 180 | Increased hepatocellular lipid droplets (HP:0006565) | 1.67252879 |
| 181 | Horizontal nystagmus (HP:0000666) | 1.66902760 |
| 182 | Ketosis (HP:0001946) | 1.66510532 |
| 183 | Intrahepatic cholestasis (HP:0001406) | 1.66031367 |
| 184 | X-linked dominant inheritance (HP:0001423) | 1.65321445 |
| 185 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.64321796 |
| 186 | Severe muscular hypotonia (HP:0006829) | 1.63724738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.93626636 |
| 2 | MARK1 | 3.58864424 |
| 3 | MAP3K9 | 3.58859863 |
| 4 | TRIM28 | 3.57058835 |
| 5 | CASK | 3.30772572 |
| 6 | MAP3K4 | 3.23720206 |
| 7 | FRK | 3.08579836 |
| 8 | EPHA4 | 3.05078126 |
| 9 | MAP2K7 | 2.93262683 |
| 10 | MAP3K12 | 2.71691401 |
| 11 | MINK1 | 2.70497812 |
| 12 | DAPK2 | 2.60326944 |
| 13 | EIF2AK1 | 2.39799802 |
| 14 | MAP2K4 | 2.17481042 |
| 15 | ACVR1B | 2.08206322 |
| 16 | PAK6 | 2.06457300 |
| 17 | MST4 | 2.04931804 |
| 18 | KSR2 | 1.96953609 |
| 19 | PLK2 | 1.90484921 |
| 20 | EIF2AK3 | 1.86979526 |
| 21 | NTRK2 | 1.84172714 |
| 22 | DAPK1 | 1.77598847 |
| 23 | CDK19 | 1.74973869 |
| 24 | BMPR1B | 1.64693615 |
| 25 | KSR1 | 1.63555196 |
| 26 | CAMKK1 | 1.62670350 |
| 27 | CSNK1G3 | 1.61668136 |
| 28 | NTRK1 | 1.56871017 |
| 29 | CSNK1G1 | 1.52240286 |
| 30 | MYLK | 1.51579585 |
| 31 | CSNK1A1L | 1.50205869 |
| 32 | PRKD3 | 1.47672878 |
| 33 | GRK5 | 1.46284864 |
| 34 | MAPK13 | 1.43449779 |
| 35 | CDK5 | 1.41646259 |
| 36 | ARAF | 1.39902556 |
| 37 | LATS2 | 1.39774303 |
| 38 | OBSCN | 1.36317427 |
| 39 | PHKG2 | 1.35349126 |
| 40 | PHKG1 | 1.35349126 |
| 41 | STK39 | 1.33424010 |
| 42 | PRPF4B | 1.28697784 |
| 43 | CAMKK2 | 1.27073041 |
| 44 | CCNB1 | 1.23882712 |
| 45 | PRKCG | 1.22038402 |
| 46 | ADRBK2 | 1.13368994 |
| 47 | MAPKAPK3 | 1.13189177 |
| 48 | PDK4 | 1.13122577 |
| 49 | PDK3 | 1.13122577 |
| 50 | SGK494 | 1.10055064 |
| 51 | SGK223 | 1.10055064 |
| 52 | MAP3K2 | 1.09511360 |
| 53 | AKT3 | 1.05035809 |
| 54 | SGK2 | 1.04083057 |
| 55 | TESK1 | 1.02130051 |
| 56 | RIPK4 | 1.01495658 |
| 57 | STK38 | 0.99328386 |
| 58 | RET | 0.99122944 |
| 59 | NEK1 | 0.98750760 |
| 60 | TAOK1 | 0.95797105 |
| 61 | STK38L | 0.94859355 |
| 62 | NEK6 | 0.93184416 |
| 63 | CAMK2A | 0.92885650 |
| 64 | PLK3 | 0.91029107 |
| 65 | STK3 | 0.90393103 |
| 66 | CDK18 | 0.89891689 |
| 67 | OXSR1 | 0.88763609 |
| 68 | MAP4K2 | 0.88268465 |
| 69 | CDK14 | 0.87589020 |
| 70 | MAP2K6 | 0.87264647 |
| 71 | ZAK | 0.86604743 |
| 72 | LMTK2 | 0.86147062 |
| 73 | SGK3 | 0.85825106 |
| 74 | SRPK1 | 0.84910534 |
| 75 | PRKCH | 0.84416737 |
| 76 | CDK15 | 0.83859716 |
| 77 | UHMK1 | 0.79713248 |
| 78 | PAK3 | 0.79278468 |
| 79 | BMPR2 | 0.78605956 |
| 80 | SIK3 | 0.78541604 |
| 81 | SCYL2 | 0.78481098 |
| 82 | SIK2 | 0.77342460 |
| 83 | CSNK1G2 | 0.74229287 |
| 84 | TNIK | 0.74154117 |
| 85 | GRK1 | 0.74144971 |
| 86 | WNK4 | 0.72970865 |
| 87 | PTK2B | 0.71068236 |
| 88 | PINK1 | 0.70767112 |
| 89 | TGFBR2 | 0.70240684 |
| 90 | CDK11A | 0.69660589 |
| 91 | CAMK2B | 0.67265714 |
| 92 | MET | 0.66730796 |
| 93 | BRAF | 0.65666766 |
| 94 | MAP3K5 | 0.65461219 |
| 95 | DYRK1A | 0.65327921 |
| 96 | ERBB4 | 0.63962463 |
| 97 | MAP3K13 | 0.63815744 |
| 98 | PRKCE | 0.63544330 |
| 99 | STK11 | 0.63332729 |
| 100 | MARK3 | 0.63319616 |
| 101 | PDK1 | 0.60353781 |
| 102 | CAMK1 | 0.60143119 |
| 103 | RAF1 | 0.60082718 |
| 104 | FES | 0.59841351 |
| 105 | PRKCI | 0.59493964 |
| 106 | TYRO3 | 0.58789210 |
| 107 | WNK3 | 0.57455427 |
| 108 | SGK1 | 0.56539502 |
| 109 | MAP3K1 | 0.56391262 |
| 110 | MAP2K1 | 0.56223818 |
| 111 | PDPK1 | 0.55721761 |
| 112 | FER | 0.54442067 |
| 113 | RPS6KA2 | 0.53767441 |
| 114 | ERBB3 | 0.52604000 |
| 115 | LIMK1 | 0.52344624 |
| 116 | PRKCZ | 0.51975489 |
| 117 | GRK7 | 0.50574627 |
| 118 | STK24 | 0.49785433 |
| 119 | BCR | 0.48240467 |
| 120 | ALK | 0.46947522 |
| 121 | NUAK1 | 0.46548346 |
| 122 | PDK2 | 0.45446967 |
| 123 | PNCK | 0.45038692 |
| 124 | MARK2 | 0.44790274 |
| 125 | DAPK3 | 0.44441531 |
| 126 | CAMK2G | 0.43752440 |
| 127 | EPHA3 | 0.41906596 |
| 128 | CLK1 | 0.41852602 |
| 129 | PRKACA | 0.41774926 |
| 130 | RPS6KA3 | 0.41657878 |
| 131 | CAMK2D | 0.41008169 |
| 132 | PIK3CG | 0.40314666 |
| 133 | INSRR | 0.38483940 |
| 134 | NEK9 | 0.37869090 |
| 135 | MAPK12 | 0.37845899 |
| 136 | TIE1 | 0.37839909 |
| 137 | PRKG1 | 0.37156972 |
| 138 | BCKDK | 0.36936809 |
| 139 | MAP3K6 | 0.36857798 |
| 140 | CDC42BPA | 0.36735379 |
| 141 | PKN1 | 0.36466107 |
| 142 | BRSK2 | 0.36099239 |
| 143 | MUSK | 0.34984463 |
| 144 | CSNK1A1 | 0.34953248 |
| 145 | CSNK1D | 0.34714832 |
| 146 | RPS6KA5 | 0.34378200 |
| 147 | ROCK1 | 0.33514974 |
| 148 | NME1 | 0.33487688 |
| 149 | FLT3 | 0.33461967 |
| 150 | TSSK6 | 0.32887187 |
| 151 | ADRBK1 | 0.32329231 |
| 152 | FYN | 0.32321899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.91952641 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.41934291 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.20241368 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.71119267 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.68027898 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.60497819 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.47439921 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45345320 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37575023 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.37276981 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.31183825 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.28832432 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.25548478 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.23887927 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.20504003 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.18549191 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.17353000 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.11608337 |
| 19 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.09112709 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.06509271 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 2.02201827 |
| 22 | Basal transcription factors_Homo sapiens_hsa03022 | 1.91446538 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89842862 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.84793114 |
| 25 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.82787571 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.74949764 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71846863 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71452099 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61140531 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60602273 |
| 31 | Taste transduction_Homo sapiens_hsa04742 | 1.60159484 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53618985 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.53338814 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.52998599 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52713950 |
| 36 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49167032 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.47781164 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.47209570 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46143427 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45902760 |
| 41 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.45476403 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42283904 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41845811 |
| 44 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.37051634 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33701552 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32444599 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 1.30993589 |
| 48 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.28467384 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.26802400 |
| 50 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22812794 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21271081 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20675513 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19925040 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19873755 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.18561103 |
| 56 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.17880264 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17267974 |
| 58 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.15741238 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 1.13303189 |
| 60 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.13241370 |
| 61 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.10856185 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07383908 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05924848 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.05306363 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03966170 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02272229 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.00257483 |
| 68 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99979644 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.98357217 |
| 70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98109015 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97495906 |
| 72 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.97123811 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.95680643 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94953514 |
| 75 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94763570 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93520237 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.92460361 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92359140 |
| 79 | Axon guidance_Homo sapiens_hsa04360 | 0.91089950 |
| 80 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90104372 |
| 81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88651499 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88504598 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87031495 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86222777 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.84863002 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.83920428 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82620034 |
| 88 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82168893 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.79442313 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79055777 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.78908659 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77048878 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.76974773 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76025357 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.75422519 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73999485 |
| 97 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.73279066 |
| 98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72308952 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.71380459 |
| 100 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.70432419 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70375797 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69592288 |
| 103 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68189357 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66041067 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64610964 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64557825 |
| 107 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62489779 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62336342 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62279385 |
| 110 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61930282 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.61114542 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60778378 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60467095 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59987214 |
| 115 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59403278 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58227829 |
| 117 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58127466 |
| 118 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58073629 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57980085 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56854305 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56797334 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55464537 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.54807243 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53866573 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53678295 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53408154 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53197928 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52877547 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52448759 |
| 130 | ABC transporters_Homo sapiens_hsa02010 | 0.52133701 |
| 131 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.50105560 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49902313 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48866173 |
| 134 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.47530746 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47502515 |
| 136 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45509309 |
| 137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.45284305 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45143680 |
| 139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45076884 |
| 140 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.44891378 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.44806276 |
| 142 | Phagosome_Homo sapiens_hsa04145 | 0.44041102 |
| 143 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43528129 |
| 144 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43304304 |
| 145 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42739339 |
| 146 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42672040 |
| 147 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42554733 |
| 148 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.42368578 |
| 149 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40953846 |
| 150 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40154908 |
| 151 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39862032 |
| 152 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38654029 |
| 153 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38136135 |
| 154 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.37601760 |
| 155 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37242141 |
| 156 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.37205757 |
| 157 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36177755 |
| 158 | Alcoholism_Homo sapiens_hsa05034 | 0.36055243 |
| 159 | Prion diseases_Homo sapiens_hsa05020 | 0.34902721 |
| 160 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33595806 |
| 161 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30701609 |
| 162 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30547405 |

